Streetbeat News

NWBO

Northwest Biotherapeutics Inc

https://nwbio.com/

CEO

Linda Powers

Employees

Industry

Pharmaceutical Preparation Manufacturing

Open

0.25

Mkt cap

487M

Volume

6.3M

High

0.36

P/E Ratio

-5.00

52-wk high

0.54

Low

0.25

Div yield

N/A

52-wk low

0.17

Northwest Biotherapeutics has secured a $5 million convertible note financing and a standby facility for up to $50 million in additional financing to support its development of DCVax® personalized immune therapies for solid tumor cancers.

Portfolio Pulse from

December 26, 2024 | 2:45 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.